SUCCESSFUL USE OF A DARUNAVIR/RITONAVIR IN FIVE PREGNANT WOMEN: PHARMACOKINETICS, EFFICACY AND SAFETY

被引：0
|
作者：
Ivanovic, J. [1 ]
Bellagamba, R. [1 ]
Tempestilli, M. [1 ]
Signore, F. [2 ]
Vallone, C. [2 ]
Pisani, G. [2 ]
Nicastri, E. [1 ]
Tommasi, C. [1 ]
Gallo, A. L. [1 ]
Fezza, R. [1 ]
Pucillo, L. P. [1 ]
Narciso, P. [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy
[2] San Camillo Forlanini Hosp, Dept Obstet & Gynaecol, Rome, Italy
来源：
INFECTION | 2011年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF TOBRAMYCIN IN PREGNANT-WOMEN - SAFETY AND EFFICACY OF A ONCE-DAILY DOSE REGIMEN
    BOURGET, P
    FERNANDEZ, H
    DELOUIS, C
    TABURET, AM
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1991, 16 (03) : 167 - 176
  • [22] Successful use of a tipranavir/ritonavir-based antiretroviral regimen following development of viral resistance to darunavir
    Pierone, Gerald, Jr.
    Urban, Theresa
    Martin, Amber
    Mieras, Jeffrey
    Kantor, Chandra
    HIV CLINICAL TRIALS, 2008, 9 (02): : 140 - 141
  • [23] The safety of amodiaquine use in pregnant women
    Tagbor, Harry K.
    Chandramohan, Daniel
    Greenwood, Brian
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (06) : 631 - 635
  • [24] Total and unbound darunavir (DRV) pharmacokinetics (PK) in HIV-1-infected pregnant women
    Zorrilla, C.
    Wright, R.
    Osiyemi, O.
    Yasin, S.
    Baugh, B.
    Brown, K.
    Coate, B.
    Verboven, P.
    Hillewaert, V
    Kakuda, T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 60 - 61
  • [25] Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children
    Chokephaibulkit, K.
    Rungmaitree, S.
    Phongsamart, W.
    Lappra, K.
    Wittawatmongkol, O.
    Kongstan, N.
    Cressey, T. R.
    HIV MEDICINE, 2014, 15 (08) : 511 - 512
  • [26] A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV
    Zhang, Haeyoung
    Hindman, Jason T.
    Lin, Ludwig
    Davis, Maggie
    Shang, Justin
    Xiao, Deqing
    Avihingsanon, Anchalee
    Arora, Priyanka
    Palaparthy, Ramesh
    Girish, Sandhya
    Marathe, Dhananjay D.
    AIDS, 2024, 38 (01) : F1 - F9
  • [27] The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women
    van der Lug, Jasper
    Colbers, Angela
    Molto, Jose
    Hawkins, David
    van der Ende, Marchina
    Vogel, Martin
    Wyen, Christoph
    Schutz, Malte
    Koopmans, Peter
    Ruxrungtham, Kiat
    Richter, Clemens
    Burger, David
    ANTIVIRAL THERAPY, 2009, 14 (03) : 443 - 450
  • [28] Pharmacokinetics of darunavir/ritonavir during pregnancy in HIV-1-infected women (vol 17, pg 643, 2016)
    Crauwels, H. M.
    Kakuda, T. N.
    Ryan, B.
    Zorilla, C.
    HIV MEDICINE, 2019, 20 (07) : 496 - 499
  • [29] Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance
    Furco, Andre
    Gosrani, Bhairvi
    Nicholas, Sara
    Williams, Amanda
    Braithwaite, Wunmi
    Pozniak, Anton
    Taylor, Graham
    Asboe, David
    Lyall, Hermione
    Shaw, Andrew
    Kapembwa, Moses
    AIDS, 2009, 23 (03) : 434 - 435
  • [30] Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients Week 48 Results of the ARIEL Trial
    Violari, Avy
    Bologna, Rosa
    Kumarasamy, Nagalingeswaran
    Pilotto, Jose Henrique
    Hendrickx, Annemie
    Kakuda, Thomas N.
    Lathouwers, Erkki
    Opsomer, Magda
    Van de Casteele, Tom
    Tomaka, Frank L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (05) : E132 - E137
12345